Aurinia Pharmaceuticals to Release Third Quarter 2022 Financial and Operational Results on November 3, 2022
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for third quarter 2022 on Thursday, November 3, 2022, before markets open. Aurinia's management team will host a conference call/webcast at 8:30 am ET that day to review these results and provide a general business update.
Interested participants can dial 877-407-9170 (Toll-free U.S. & Canada). The audio webcast can also be accessed under "News/Events" through the "Investors" section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia's website.
About Aurinia
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2021, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis (LN). The Company's head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...
Doré Copper Mining Corp. (the "Corporation" or "Doré Copper") has granted 4,215,000 stock options to management, consultants and advisors. The stock options have an exercise price of $0.10 per share and a term of five years. The Company has also...
Evergy, Inc. announced today it will release its 2024 first quarter earnings Thursday, May 9, 2024, before market open. The company plans to host its quarterly conference call and audio webcast to discuss the results Thursday, May 9, 2024....
The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against The Chemours Company ("Chemours" or the "Company") ....
BMO Asset Management Inc. ("BMOAM Inc."), the manager of the BMO ETFs, today announced notional non-cash reinvested distributions (each a "Notional Distribution") and tax adjustments for certain BMO ETFs.
A Notional Distribution occurs when a BMO...
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced The Middleby Corp. as its "Stock to Study" and UnitedHealth Group as its "Undervalued Stock" in the June/July 2024 issue for investors' informational...
